{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:58:40Z","timestamp":1769047120310,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.cct.2013.05.002","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T06:30:17Z","timestamp":1368167417000},"page":"97-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Increasing antiviral treatment through integrated hepatitis C care: A randomized multicenter trial"],"prefix":"10.1016","volume":"35","clinical-trial-number":[{"clinical-trial-number":"nct00722423","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Erik J.","family":"Groessl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Sklar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramsey C.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Br\u00e4u","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel B.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2013.05.002_bb0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/jlts.2003.50073","article-title":"Projecting future complications of chronic hepatitis C in the United States","volume":"9","author":"Davis","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cct.2013.05.002_bb0010","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/hep.21826","article-title":"Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study","volume":"46","author":"Bruno","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cct.2013.05.002_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2011.03.004","article-title":"A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C","volume":"9","author":"Backus","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cct.2013.05.002_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1586\/eri.10.153","article-title":"Overview of the PROVE studies evaluating the use of telaprevir in chronic hepatitis C genotype 1 patients","volume":"9","author":"Burney","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cct.2013.05.002_bb0025","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection","volume":"364","author":"Poordad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cct.2013.05.002_bb0280","series-title":"HCV Viremic Veterans in VHA Care in 2011 with First Fill or Ever Filled a VHA Outpatient Prescription for HCV Antiviral Medications for the Nation, by VISN and by Station","article-title":"VA Center for Quality Management in Public Health","year":"2012"},{"key":"10.1016\/j.cct.2013.05.002_bb0035","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/j.1572-0241.2008.01877.x","article-title":"Management of chronic hepatitis C in veterans: the potential of integrated care models","volume":"103","author":"Ho","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cct.2013.05.002_bb0285","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/jhep.2002.37117","article-title":"National Institutes of Health consensus development conference statement: Management of hepatitis C: 2002","volume":"36","author":"NIH","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cct.2013.05.002_bb0045","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1111\/j.1572-0241.2006.00754.x","article-title":"Management and treatment of hepatitis C viral infection: recommendations from the department of veterans affairs hepatitis C resource center program and the national hepatitis C program office","volume":"101","author":"Yee","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cct.2013.05.002_bb0050","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1365-2893.2012.01648.x","article-title":"Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients","volume":"19","author":"Charlebois","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cct.2013.05.002_bb0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/600304","article-title":"Hepatitis C treatment for injection drug users: a review of the available evidence","volume":"49","author":"Hellard","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cct.2013.05.002_bb0060","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/j.1572-0241.2006.00731.x","article-title":"Integrated psychiatric\/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes","volume":"101","author":"Knott","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cct.2013.05.002_bb0065","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jsat.2012.08.007","article-title":"Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program","volume":"43","author":"Stein","year":"2012","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.cct.2013.05.002_bb0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00004583-199101000-00008","article-title":"Concurrent validity and psychometric properties of the Beck Depression Inventory in outpatient adolescents","volume":"30","author":"Ambrosini","year":"1991","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.cct.2013.05.002_bb0075","series-title":"The Alcohol Use Disorders Identification Test: guidelines for use in primary health care","author":"Babor","year":"1992"},{"key":"10.1016\/j.cct.2013.05.002_bb0080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1530-0277.2002.tb02534.x","article-title":"The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research","volume":"26","author":"Reinert","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cct.2013.05.002_bb0085","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/mpr.169","article-title":"Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI)","volume":"13","author":"Kessler","year":"2004","journal-title":"Int J Methods Psychiatr Res"},{"key":"10.1016\/j.cct.2013.05.002_bb0290","series-title":"Management of psychiatric and substance use disorders in patients with hepatitis C: A reference for hepatitis C care providers","first-page":"1","article-title":"Hepatitis C Resource Center Program and National Hepatitis C Program Office","author":"VA","year":"2005"},{"key":"10.1016\/j.cct.2013.05.002_bb0295","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1185\/135525703125002360","article-title":"The primary care PTSD screen (PC-PTSD): development and operating characteristics","volume":"9","author":"Prins","year":"2003","journal-title":"Primary Care Psychiatry"},{"key":"10.1016\/j.cct.2013.05.002_bb0100","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1053\/jhep.2003.50364","article-title":"Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C","volume":"38","author":"Davis","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cct.2013.05.002_bb0105","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1002\/hep.1840360720","article-title":"The role of liver biopsy in chronic hepatitis C","volume":"36","author":"Dienstag","year":"2002","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.cct.2013.05.002_bb0110","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1080\/09540120412331315295","article-title":"Literature on integrated HIV care: a review","volume":"16","author":"Soto","year":"2004","journal-title":"AIDS Care"},{"key":"10.1016\/j.cct.2013.05.002_bb0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0376-8716(96)01263-X","article-title":"The reliability of the Alcohol Timeline Followback when administered by telephone and by computer","volume":"42","author":"Sobell","year":"1996","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.cct.2013.05.002_bb0120","doi-asserted-by":"crossref","first-page":"304","DOI":"10.15288\/jsad.2009.70.304","article-title":"Reliability and validity of the alcohol short index of problems and a newly constructed drug short index of problems","volume":"70","author":"Alterman","year":"2009","journal-title":"J Stud Alcohol Drugs"},{"key":"10.1016\/j.cct.2013.05.002_bb0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.drugalcdep.2003.11.005","article-title":"Convergent and concurrent validity of the Contemplation Ladder and URICA scales","volume":"73","author":"Amodei","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.cct.2013.05.002_bb0130","series-title":"Timeline followback User's Guide: A Calendar Method for Assessing Alcohol and Drug Use","author":"Sobell","year":"1996"},{"issue":"Suppl. 20","key":"10.1016\/j.cct.2013.05.002_bb0300","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.cct.2013.05.002_bb0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0163-8343(02)00207-4","article-title":"Screening for post-traumatic stress disorder in female Veteran's Affairs patients: validation of the PTSD checklist","volume":"24","author":"Dobie","year":"2002","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.cct.2013.05.002_bb0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1037\/0893-164X.19.1.71","article-title":"Indicators of client engagement: influences on alcohol treatment satisfaction and outcomes","volume":"19","author":"Dearing","year":"2005","journal-title":"Psychol Addict Behav"},{"key":"10.1016\/j.cct.2013.05.002_bb0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/A:1008884805251","article-title":"A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C","volume":"7","author":"Bayliss","year":"1998","journal-title":"Qual Life Res"},{"key":"10.1016\/j.cct.2013.05.002_bb0155","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.510300203","article-title":"Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group","volume":"30","author":"Ware","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cct.2013.05.002_bb0160","series-title":"Quality of Life and Pharmacoeconomics in Clinical Trials","article-title":"The EuroQol instrument: an index of health-related quality of life","author":"Kind","year":"1996"},{"key":"10.1016\/j.cct.2013.05.002_bb0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0033-3182(93)71928-3","article-title":"Abbreviating the Duke Social Support Index for use in chronically ill elderly individuals","volume":"34","author":"Koenig","year":"1993","journal-title":"Psychosomatics"},{"key":"10.1016\/j.cct.2013.05.002_bb0170","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jclinepi.2007.02.006","article-title":"A simple sample size formula for analysis of covariance in randomized clinical trials","volume":"60","author":"Borm","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cct.2013.05.002_bb0305","series-title":"SISA-Binomial","author":"Uitenbroek","year":"1997"},{"key":"10.1016\/j.cct.2013.05.002_bb0310","series-title":"Hypothesis Testing: Categorical Data \u2014 Estimation of Sample Size and Power for Comparing Two Binomial Proportions in Bernard Rosner's Fundamentals of Biostatistics","first-page":"381","author":"Rosner","year":"2011"},{"key":"10.1016\/j.cct.2013.05.002_bb0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0033-3182(10)70675-7","article-title":"Significant reductions in drinking following brief alcohol treatment provided in a hepatitis C clinic","volume":"51","author":"Dieperink","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.cct.2013.05.002_bb0190","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1001\/archinte.159.16.1946","article-title":"A randomized trial of integrated outpatient treatment for medically ill alcoholic men","volume":"159","author":"Willenbring","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cct.2013.05.002_bb0195","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1001\/jama.289.23.3145","article-title":"Educational and organizational interventions to improve the management of depression in primary care: a systematic review","volume":"289","author":"Gilbody","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2013.05.002_bb0200","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archpsyc.56.12.1109","article-title":"Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial","volume":"56","author":"Katon","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.cct.2013.05.002_bb0205","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/bmj.38683.710255.BE","article-title":"Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care","volume":"332","author":"Hunkeler","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2013.05.002_bb0315","series-title":"Management of Psychiatric and Substance Use Disorders in Patients With Hepatitis C:A Reference for Hepatitis C Care Providers","article-title":"The VA Hepatitis C Resource Center Program and National Hepatitis C Program Office","year":"2005"},{"key":"10.1016\/j.cct.2013.05.002_bb0320","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2009.09.067","article-title":"Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression","volume":"138","author":"Davis","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cct.2013.05.002_bb0220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0376-8716(02)00010-8","article-title":"Treating hepatitis C in methadone maintenance patients: an interim analysis","volume":"67","author":"Sylvestre","year":"2002","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl. 5","key":"10.1016\/j.cct.2013.05.002_bb0225","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.1086\/427447","article-title":"Treating hepatitis C virus infection in active substance users","volume":"40","author":"Sylvestre","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cct.2013.05.002_bb0230","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.drugpo.2007.01.010","article-title":"Integrating HCV services for drug users: a model to improve engagement and outcomes","volume":"18","author":"Sylvestre","year":"2007","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.cct.2013.05.002_bb0235","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/ajg.2011.219","article-title":"A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment","volume":"106","author":"Evon","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cct.2013.05.002_bb0240","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2165\/11635560-000000000-00000","article-title":"Interferon-free hepatitis C therapy: how close are we?","volume":"72","author":"Pockros","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.cct.2013.05.002_bb0245","first-page":"428A","article-title":"Impact of sustained virologic response to pegylated interferon\/ribavirin on all-cause mortality by HCV genotype in a large real-world cohort: The US Department of Veterans Affairs' experience","volume":"52","author":"Backus","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cct.2013.05.002_bb0250","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2012.03.021","article-title":"National patterns and predictors of liver biopsy use for management of hepatitis C","volume":"57","author":"Groessl","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.cct.2013.05.002_bb0255","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/bmj.325.7370.961","article-title":"Unwarranted variations in healthcare delivery: implications for academic medical centres","volume":"325","author":"Wennberg","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2013.05.002_bb0325","first-page":"3","article-title":"Practice variation: implications for our health care system","volume":"13","author":"Wennberg","year":"2004","journal-title":"Manag Care"},{"key":"10.1016\/j.cct.2013.05.002_bb0265","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/bmj.328.7441.702","article-title":"CONSORT statement: extension to cluster randomised trials","volume":"328","author":"Campbell","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2013.05.002_bb0270","first-page":"464","article-title":"Management of patients who are not candidates for protease inhibitor therapy","volume":"8","author":"Pockros","year":"2012","journal-title":"Gastroenterol Hepatol"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714413000694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714413000694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T23:28:14Z","timestamp":1539646094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714413000694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1551714413000694"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2013.05.002","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing antiviral treatment through integrated hepatitis C care: A randomized multicenter trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2013.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}